12:00 AM
 | 
Apr 14, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Presidio Pharmaceuticals Inc.

San Francisco, Calif.

Technology: Nuclear Exclusion Technology (NEXT)

Disease focus: Infectious

Clinical status: Preclinical

Founded: 2006 by...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >